The 2024 CEO Roundtable on Cancer Annual Meeting is now the 2024 Partnership Summit

The Summit will still feature panels on how we are reimagining oncology clinical trials with our members and partners. We look forward to seeing you, hearing from you, and moving forward with our work in partnership. Your engagement will ensure a provocative exchange of ideas on the current state of cancer clinical research. Our attendance will include members and partners from government, non-government organizations, academic institutions and health systems. These collaborations are critical to moving this work forward.

The CEO Roundtable Partnership Summit on Feb. 29 and March 1 will also highlight our engagement with the Cancer Moonshot and Cancer Stage Shifting Initiative, Going for Gold, and our Access, Choice and Education (ACE) Cohort in Clinical Trials.

Our traditional Annual Meeting will be rescheduled for later this year; details will be shared as soon as they are available.